Tandem Diabetes Care

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$282,648
$363,289
$221,910
$191,674
Gross Profit
157,455
124,653
112,794
94,672
EBITDA
4,215
-16,538
-23,842
-33,589
EBIT
-30
-20,749
-27,949
-37,632
Net Income
755
-23,251
-30,814
-42,715
Net Change In Cash
282,648
363,289
221,910
191,674
Free Cash Flow
-38,756
21,540
-11,741
-12,453
Cash
69,234
49,039
47,697
58,979
Basic Shares
66,157
65,538
64,994
65,325

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$940,203
$747,718
$801,217
$702,799
Gross Profit
489,574
367,690
412,986
376,215
EBITDA
-99,127
-194,657
-72,314
36,498
EBIT
-210,372
-86,644
22,653
Net Income
-96,025
-222,611
-94,594
15,566
Net Change In Cash
940,203
747,718
801,217
702,799
Cost of Revenue
100,509
-23,585
Free Cash Flow
4,994
-83,413
7,512
87,848
Cash
69,234
58,868
172,517
71,181
Basic Shares
65,451
64,968
64,146
64,349

Earnings Calls

Quarter EPS
2024-12-31
-$0.43
2024-09-30
-$0.35
2024-06-30
-$0.48
2024-03-31
-$0.63